RUCHI MALIK

Employment

• Central University of Rajasthan Assistant Professor
  2013 - Present
• BR Nahata College of Pharmacy Professor and Head
  2011 - 2014
• Lovely Professional University Associate Dean
  2010 - 2010
• BR Nahata College of Pharmacy Associate Dean
  2008 - 2010
• BR Nahata College of Pharmacy Reader
  2006 - 2011
• Panjab University Institute of Pharmaceutical Sciences Project Associate
  2002 - 2006
• Shri Guru Ram Rai Institute of Technology and Science Department of Pharmaceutical Sciences Lecturer
  2001 - 2002

Education

• Panjab University Institute of Pharmaceutical Sciences M. Pharm.
  1999 - 2001
• Panjab University Institute of Pharmaceutical Sciences B. Pharm.
  1995 - 1999
• Panjab University Institute of Pharmaceutical Sciences Ph.D.
  ? - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (47)

• Exploring 2‐Thioxo‐1,2,3,4‐tetrahydropyrimidines as Dual Acting GSK‐3β/Aβ Aggregation Inhibitors: Implications for Alzheimer's Disease Treatment
  Drug Development Research 2025 DOI: 10.1002/ddr.70112
  +Save
• Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3β/Aβ aggregation inhibitor and anti-Alzheimer’s agent
  Bioorganic Chemistry 2024 DOI: 10.1016/j.bioorg.2024.107811
  +Save
• 1,3,5-triazine derivatives as potential anticancer agents against lung and breast cancer cell lines: Synthesis, biological evaluation, and structure-based drug design studies
  Journal of Molecular Structure 2024 DOI: 10.1016/j.molstruc.2024.138078
  +Save
• Discovery of Benzoxazepines as a New Class of PIM1 Kinase Inhibitors Through Structure Based Virtual Screening, Biochemical Evaluation and Cytotoxicity Studies
  ChemistrySelect 2024 DOI: 10.1002/slct.202304650
  +Save
• Identification and mechanistic exploration of structural and conformational dynamics of NF-kB inhibitors: rationale insights from in silico and in vitro studies
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2023.2200490
  +Save
• Discovery of a New Dihydropyrimidinone Derivative as a Potential Haspin Kinase Inhibitor: Structure‐Guided Insights, In‐Vitro and Molecular Dynamics‐Based Validation
  ChemistrySelect 2023 DOI: 10.1002/slct.202301233
  +Save
• Structure-based virtual screening, biological assessment, and MD simulation studies of novel CNS compatible GSK-3β inhibitors as potential Alzheimer’s disease therapeutics.
  2022 DOI: 10.21203/rs.3.rs-1309750/v1
  +Save
• 2-Pyridin-4-yl-methylene-beta-boswellic Acid─A Potential Candidate for Targeting O6-Methylguanine-DNA Methyltransferase Epi-transcriptional Reprogramming in KRAS G13D─Microsatellite Stable, G12V─Microsatellite Instable Mutant Colon Cancer
  ACS Pharmacology & Translational Science 2022 DOI: 10.1021/acsptsci.1c00228
  +Save
• Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents
  ChemMedChem 2022 DOI: 10.1002/cmdc.202200002
  +Save
• Identification of CNS compatible small molecules as glycogen synthase kinase-3β (GSK-3β) inhibitors through structure-based virtual screening
  Medicinal Chemistry Research 2022 DOI: 10.1007/s00044-022-02912-z
  +Save